Navigation Links
Global Neuroendocrine Carcinoma Therapeutics Market To Reach $475m By 2019 - Report
Date:7/2/2012

NEW YORK, LONDON, BERLIN and PARIS, July 2, 2012 /PRNewswire/ --

The global Neuroendocrine carcinoma therapeutics market was worth $127m in 2011 and now the market is forecast to grow at Compound Annual Growth Rate (CAGR) of 17.9% to reach $475m by 2019. The high growth is primarily attributed to the advent of approved drugs, Sutent (sunitinib) and Afinitor (everolimus), in the major markets. The expected launch of promising drugs in the forecast period will drive the market. The promising drugs to be launched include: Avastin (bevacizumab) and Lutathera ([177Lutetium]-DOTA0-Tyr3-Octreotate) for Gastrointestinal (GI) carcinoid and pancreatic Neuroendocrine Tumors (NETs), pasireotide (SOM 230), and Somatuline (lanreotide acetate) Autogel/Depot for GI carcinoids NETs. These factors will accelerate the growth of the neuroendocrine carcinoma therapeutics market.

Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019 report is an essential source of information and analysis on the global Neuroendocrine carcinoma market. The report identifies the key trends shaping and driving the market. It also provides insights on the prevalent competitive landscape and the emerging players that are expected to significantly alter the positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products in the glob
'/>"/>

SOURCE Reportstack.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... The first part of the session on ... Human Studies” will cover comprehensive clinical support in early ... increasing R&D costs and declining industry success in getting ... knowledge collected in early Phase I/IIa study data to ... stage development. , Next, the presenters will examine steps ...
(Date:7/24/2014)... , July 24, 2014   Cypher ... today the appointment of Adam Simpson ... Genomics provides rapid and comprehensive annotation and interpretation ... clinical reporting. "Cypher,s technology has the ... healthcare by enhancing diagnostic accuracy, optimizing therapeutic approaches ...
(Date:7/23/2014)... NEW YORK , July 24, 2014 /PRNewswire/ ... and Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX ... "IMNP."; "Immune" or "the Company"), announced a collaboration ... bullous pemphigoid last night at an event attended ... other interested parties. Lyfebulb is a health and ...
(Date:7/23/2014)... great strides in saving China,s endangered national treasure, the ... giant panda reserves that have been established and three ... pandas remain in the wild. , Breeding programs ... panda by improving genetic diversity, avoid inbreeding and ultimately, ... these high-profile programs doing so far? , In a ...
Breaking Biology Technology:Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 3Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 2Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 3Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 4Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 5
... Fund More Than Doubles Assets Under Management, UTRECHT, ... growing European venture capital firm, today announced,the closing of ... Gilde,Healthcare II (GHC II). The new fund, which is ... funds raised to invest in European,healthcare opportunities. GHC II ...
... Emerging Nanotechnologies will host the U.S. launch of ... Responsible Nanotechnology aimed principally at businesses and research ... Society and the United Kingdom government-sponsored Nanotechnology Knowledge ... Association, Insight Investment. , The event ...
... Genmab Antibody,Summary: Genmab,s Partner Roche has Filed a CTA With the ... ... COPENHAGEN, October 2 Genmab A/S (OMX: GEN),announced today that ... British Medicines and Healthcare products,Regulatory Agency (MHRA) for a Genmab antibody ...
Cached Biology Technology:Gilde Healthcare Partners Closes EUR 150 Million European Healthcare Venture Fund 2A new 'responsible nanocode' for business 2Genmab A/S - Company Announcement 2
(Date:7/23/2014)... risk warning for Yellowknife and surrounding area because of ... In the image taken by the Aqua satellite, ... Fire is an obvious health hazard, but the ... obvious and its effects are insidious. , The smoke ... structure, tires, waste or wood burning) is a mixture ...
(Date:7/23/2014)... entire country in its grip is affecting more than the ... the proliferation of a heat-loving amoeba commonly found in warm ... the drought has made warmer than usual this year. , ... by this parasite after swimming in several area lakes. The ... and travels to the brain. Nose plugs can lower the ...
(Date:7/23/2014)... This news release is available in German . ... shape and stability to cells, drive metabolic processes and ... into complex three-dimensional shapes. Scientists at the Max Planck ... that proteins can be constructed of similar amino acid ... suggests that the proteins that exist today arose from ...
Breaking Biology News(10 mins):Diseases of another kind 2Protein evolution follows a modular principle 2
... has destroyed 17 percent of the native vegetation in ... new study published by Conservation International sounds an alarm ... Continued deforestation at the current rate would cause all ... years, according to CI researchers in Brazil. , Overall, ...
... It's one of those unavoidable facts of life -- ... internal temperatures cause only temporary discomfort, but in some ... , These convulsions are "scary and very upsetting to ... chair of Neurology. They've also been something of an ...
... shows that robot assisted knee surgery is significantly ... of surgeons tested whether Acrobot, a robotic assistant, ... knee replacement. Acrobot works by helping the surgeon ... the existing bones. , The surgeons looked at ...
Cached Biology News:Report shows deforestation threatens Brazil's Pantanal 2Molecular mechanism may explain how fevers spark seizures 2Molecular mechanism may explain how fevers spark seizures 3Robot assisted surgery more accurate than conventional surgery 2
Spectrolyse (pL) PAI kit is a two-stage indirect enzymatic assay for the quantitative determination of Plasminogen Activator Inhibitor (PAI-1) activity in plasma. Sample Type: plasma...
NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody...
... human cardiac troponin subunit T, a 31kDa protein ... contraction of cardiac muscle. It reacts with subunit ... It also cross-reacts with human skeletal troponin T ... Highly purified human cardiac troponin T ...
... is pleased to offer the ATTO-TAG ... detection of primary amines. Developed by ... the ATTO-TAG reagents are similar to ... (NDA) and anthracene-2,3-dicarboxaldehyde, all of which ...
Biology Products: